Speaker illustration

Doctor Carol Whelan

University College London, London (United Kingdom of Great Britain & Northern Ireland)

Dr Carol Whelan was appointed as Consultant Cardiologist with an interest in imaging, heart failure and cardiac amyloidosis, in October 2009 at the Royal Free London NHS Foundation Trust. She has been conferred the title of Honorary Associate Professor at UCL in recognition for her work at the National Amyloidosis Centre. She became the hospital clinical lead for Heart Failure in 2011. She was appointed lead for the Heart Failure Clinical Pathways Group work at the Trust in 2018. In November 2019, Dr Whelan was appointed as councillor on the board of the British Society for Heart Failure. She wrote the chapter on cardiac amyloidosis in the latest Oxford Textbook of Heart Failure and has published widely on this subject. As a clinical expert to NICE, she recently assisted them in their evaluation of two novel treatments, inotersen and patisiran, for hereditary transthyretin amyloidosis. These have both been approved.

Transforming Outcomes for Patients with hATTR Amyloidosis

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiac Amyloidosis

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk